3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting clinical attention due to initial data suggesting different biological properties. Present analyses indicate that 3-HPC may exhibit independent responses on the central nervous system, possibly influencing to some of the unexpected symptoms linked with PCP… Read More